Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Helicobacter pylori vacA Antibody (N02-H1)

Catalog #:   RXX18405 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA, FCM, SPR, WB
Accession: Q48245, P55981
Overview

Catalog No.

RXX18405

Species reactivity

Helicobacter pylori (Campylobacter pylori), Helicobacter pylori (strain ATCC 700392 / 26695) (Campylobacter pylori)

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Applications

ELISA, FCM, SPR, WB

Target

Vacuolating cytotoxin autotransporter, Vacuolating cytotoxin, Vacuolating cytotoxin translocator, vacA, Vacuolating cytotoxin autotransporter, Vacuolating cytotoxin, Vacuolating cytotoxin translocator, vacA, HP_0887

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q48245, P55981

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

N02-H1

Note

For research use only.

Data Image
References

Therapeutic Protection Against H. pylori Infection in Mongolian Gerbils by Oral Immunization With a Tetravalent Epitope-Based Vaccine With Polysaccharide Adjuvant., PMID:31191547

Review: Pathogenesis of Helicobacter pylori infection., PMID:31486234

Performance of multiplex serology in discriminating active vs past Helicobacter pylori infection in a primarily African American population in the southeastern United States., PMID:31746104

Differences in antibody levels to H. pylori virulence factors VacA and CagA among African Americans and whites in the Southeast USA., PMID:32222845

Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis., PMID:32253703

Antibody Responses to Helicobacter pylori and Risk of Developing Colorectal Cancer in a European Cohort., PMID:32332031

Chronic in vivo exposure to Helicobacter pylori VacA: Assessing the efficacy of automated and long-term intragastric toxin infusion., PMID:32518315

PCR analysis and specific immunohistochemistry revealing a high prevalence of non-Helicobacter pylori Helicobacters in Helicobacter pylori-negative gastric disease patients in Japan: High susceptibility to an Hp eradication regimen., PMID:32790220

Effects of Multi-Strain Probiotics on Immune Responses and Metabolic Balance in Helicobacter pylori-Infected Mice., PMID:32824501

Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile., PMID:32898138

CD103 Promotes the Pro-inflammatory Response of Gastric Resident CD4+ T Cell in Helicobacter pylori-Positive Gastritis., PMID:32974219

Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer., PMID:33143263

Prevalence and associated risk factors of Helicobacter pylori infection in the Wuwei cohort of north-western China., PMID:33159827

Immune evaluation of a Saccharomyces cerevisiae-based oral vaccine against Helicobacter pylori in mice., PMID:33219579

Serodiagnosis and Bacterial Genome of Helicobacter pylori Infection., PMID:34357939

Helicobacter pylori induced Immune Thrombocytopenic Purpura and perspective role of Helicobacter pylori eradication therapy for treating Immune Thrombocytopenic Purpura., PMID:34708173

HomA and HomB, outer membrane proteins of Helicobacter pylori down-regulate activation-induced cytidine deaminase (AID) and Ig switch germline transcription and thereby affect class switch recombination (CSR) of Ig genes in human B-cells., PMID:34959071

Transient recombinant expression of highly immunogenic CagA, VacA and NapA in Nicotiana benthamiana., PMID:35028298

Association between Helicobacter pylori antibodies determined by multiplex serology and gastric cancer risk: A meta-analysis., PMID:35212073

Serum antibodies to selected Helicobacter pylori antigens are associated with active gastritis in patients seen at the University Teaching Hospital in Lusaka, Zambia., PMID:37265823

Associations of lung cancer risk with biomarkers of Helicobacter pylori infection., PMID:35605986

Association of human leukocyte antigen DQ-rs3920AG genotype with Helicobacter pylori recurrence in Kafrelsheikh, Egypt., PMID:35717663

Oral Immunization With a M Cell-Targeting Recombinant L. Lactis Vaccine LL-plSAM-FVpE Stimulate Protective Immunity Against H. Pylori in Mice., PMID:35911756

Electrochemical Immunosensor for Detection of H. pylori Secretory Protein VacA on g-C3N4/ZnO Nanocomposite-Modified Au Electrode., PMID:36120075

Potential Antigenic Candidates for the Development of Peptide-Based Vaccines to Induce Immunization against Helicobacter pylori Infection in BALB/c Mice., PMID:36361614

Helicobacter pylori infection: is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein?, PMID:36463198

Treatment with Helicobacter pylori-derived VacA attenuates allergic airway disease., PMID:36761723

Causal associations of circulating Helicobacter pylori antibodies with stroke and the mediating role of inflammation., PMID:37184658

Helicobacter pylori infection altered gastric microbiota in patients with chronic gastritis., PMID:37662018

Expression and purification of epitope vaccine against four virulence proteins from Helicobacter pylori and construction of label-free electrochemical immunosensor., PMID:37804573

A multiserological line assay to potentially discriminate current from past Helicobacter pylori infection., PMID:37827383

No evident causal association between Helicobacter pylori infection and colorectal cancer: a bidirectional mendelian randomization study., PMID:37899462

No potential causal link between HP infection and IBD: A 2way Mendelian randomization study., PMID:38394482

Causal association between helicobacter pylori and atherosclerosis: a two-sample Mendelian randomization., PMID:38491418

Establishment of an intragastric surgical model using C57BL/6 mice to study the vaccine efficacy of OMV-based immunogens against Helicobacter pylori., PMID:38602383

Detection of Helicobacter pylori strain types and analysis of risk factors among subjects from Hainan Province, China., PMID:38759213

Helicobacter pylori positive oral squamous cell carcinoma demonstrate higher pathological tumor staging and poorer overall survival., PMID:38906379

Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection., PMID:38937679

Outer membrane vesicles from genetically engineered Salmonella enterica serovar Typhimurium presenting Helicobacter pylori antigens UreB and CagA induce protection against Helicobacter pylori infection in mice., PMID:38937901

Analysis of the Association Between Pathogen Exposure and the Risk of Dementia., PMID:38995782

Analyses of the association between Helicobacter pylori antibody titre and pathogenicity before and after eradication: results of the Kyushu and Okinawa population study, a retrospective observational cohort study., PMID:39117418

Causal associations between Helicobacter Pylori infection and the risk and symptoms of Parkinson's disease: a Mendelian randomization study., PMID:39165356

Rapid profiling of carcinogenic types of Helicobacter pylori infection via deep learning analysis of label-free SERS spectra of human serum., PMID:39329094

Association of Antibody Responses to Helicobacter pylori Proteins with Colorectal Adenoma and Colorectal Cancer., PMID:39452767

Causal associations of Helicobacter pylori infection and metabolic syndrome: insights from a two-sample Mendelian randomization study., PMID:39587686

Prevalence of Helicobacter pylori infection in the general population in Wuzhou, China: a cross-sectional study., PMID:39780274

Assessment of the bidirectional causal association between Helicobacter pylori infection and allergic diseases by mendelian randomization analysis., PMID:39962134

Efficacy and eradication effect of vonoprazan and high-dose amoxicillin dual therapy in CagA+VacA+ Helicobacter pylori infected patients., PMID:40181762

Development of a Recombinant Outer Membrane Vesicles (OMVs)-Based Vaccine Against Helicobacter pylori Infection in Mice., PMID:40421643

High Seroprevalence of Helicobacter pylori and CagA/VacA Virulence Factors in Northern Central America., PMID:40503193

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Helicobacter pylori vacA Antibody (N02-H1) [RXX18405]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only